We could not find exactly the information you wanted. Below are links to similar stories...
TargetPrint, a test for breast cancer specimens, was recently launched by Agendia. This new diagnostic test was designed to evaluate expression of a number of different genes important in treatment decision making for malignancy of the breast.
Dilon Technologies developed a new transportable version of the company’s Dilon 6800 Gamma Camera. The new Dilon 6800 Access was launched to expand the utility of the camera, allowing one system to be used at a variety of different centers.
SenoRX, Incorporated received an additional marketing approval from the Food and Drug Administration for the company’s Contura MLB short-term breast radiation balloon. The company has a new device that was launched.
A study that was just published in the Journal of the American Medical Association describes the outcomes associated with stents, comparing drug eluting (DES) and bare metal stents (BMS). The study was completed in light of concerns that DES may be accompanied by an increased risk of stent thrombostenosis.
A number of Veterans Affairs facilities, as well as the Naval base in Balboa, California completed contracts with Swissray International for new flat panel monitors. The new facilities will each implement the flat panel DR systems available from the provider of digital radiography technology. The news was announced on the Swissray website in a press […]
MEDIHONEY Wound and Burn Dressing, a product manufactured by Derma Sciences was used to treat a patient with an intractable wound. Following treatment, the wound resolved 90 percent (pdf) within a three week timeframe.
Completion of a definitive agreement was announced by Boston Scientific Corporation to sell the company’s investments in an array of different companies to Saints Capital. A number of conditions and terms must still be negotiated in order to finalize the deal.
Covidien announced the launch of the Sandman Info and the Sandman Auto CPAP devices. These tools will expand the company’s line of products to treat patients with sleep disorders.
The SpineAssist system, manufactured by Mazor Surgical Technologies, Incorporated, received an expanded indication from the Food and Drug Administration. News of the approval was posted by Globes.
The Centers for Medicare and Medicaid Services (CMS) is evaluating providing reimbursement of CT colonography as a tool for colon cancer screening. The organization commenced a national coverage analysis, considering the existing evidence, to determine if reimbursement is warranted. Health Imaging posted the news on their website.
The ALTRUA line of pacemakers from Boston Scientific Corporation has been cleared by the U.S. Food and Drug Administration for marketing. The company issued a press release describing the approval in the U.S.
A study presented at the ARRS meeting indicates that both outpatient clinics and hospitals will not need to upgrade or purchase new CT systems to address growing rates of participation in colon cancer screening. The facilities have adequate multislice CT capacity to meet these needs, as reported on Diagnostic Imaging.
The Centers for Medicare and Medicaid Services (CMS) has delivered a positive National Coverage Determination to Abiomed for the company’s AbioCor Total Replacement Heart. This device is intended to treat patients with heart failure, as described in a press release issued by Abiomed about the determination decision from CMS.
Two private equity firms, Avista Capital Partners and Nordic Capital, have reached an agreement with Bristol-Myers Squibb whereby the two purchase Bristol’s wound therapy and surgical care unit, ConvaTec. An announcement detailing the deal was printed on the Bristol Myers website. The purchase price is $4.1 billion and the deal is expected to close during […]
Angiotech Pharmaceuticals, Incorporated has expanded their line of sutures (pdf) with the FDA approval of smaller sized Quill sutures. A news release was issued by the company describing the expansion of the product line. The suture line is being displayed at the Annual Meeting of the American Society for Aesthetic Plastic Surgery.
The Journal of the American Medical Association (JAMA) included a new report to evaluate the efficacy of a new drug-coated stent, the Xience stent, from Abbott Laboratories. The newest stent is coated with everolimus. In the trial, the study was compared to the Taxus stent.
An agreement between Shenzhen Goldway Industrial, Incorporated and Royal Philips Electronics was completed whereby Philips will acquire the remaining shares of Shenzen. The terms of the deal were not publicly disclosed. The deal is expected to close by the end of the second quarter.
The new SecondLook digital computer-aided detection (CAD) system from iCAD received marketing clearance from the Food and Drug Administration. The diagnostic tool will be bundled with Fujifilm Medical Systems’s Computed Radiography for Mammography (FCRm) system. iCAD published a press release describing the product approval.
At the annual meeting of the European Society of Radiology, a presentation about the forthcoming developments for functional MR and PET studies were described. News about the presentation was described in Diagnostic Imaging.
A study presented at the European Society of Radiology meeting in Vienna indicates that the risk of developing radiation-induced malignancy is substantially lower than has been previously reported. CT imaging has been somewhat controversial of late, with some experts suggesting that use of imaging technology can increase the risk of patients developing radiation-induced cancers. This […]
